XML 31 R11.htm IDEA: XBRL DOCUMENT v3.25.4

Inventory

12 Months Ended

Dec. 31, 2025

Inventory

Inventory

5.           Inventory

Inventory consisted of the following:

​

​	​	​	​	​	​	​
​	​	December 31,		​	December 31,
​	​ ​ ​	2025		​	2024
Raw materials	​	$	9,968	​	$	9,972
Semi-finished goods	​		29,399	​		—
Finished goods	​	​	20,555	​	​	21,246
Total inventory	​	$	59,922	​	$	31,218
Balance Sheet Classification:	​	​	​	​	​	​
Inventory	​	$	54,895	​	$	26,364
Other long-term assets	​	​	5,027	​	​	4,854
Total inventory	​	$	59,922	​	$	31,218

​

As of December 31, 2025, $20,883 of semi-finished goods were associated with the Company’s technology transfer of ARCALYST drug substance manufacturing to a new facility, which is pending regulatory approval. The Company believes it is probable that regulatory approval will be obtained, and all such inventory will be available for commercial distribution in the future.

X

- References

No definition available.

+ Details

Name:	us-gaap_InventoryDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 330
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/330/tableOfContent

+ Details

Name:	us-gaap_InventoryDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration